The India Intravenous Anesthetic Market, estimated at USD 77.7 Mn in 2025, is expected to exhibit a CAGR of 3.2% and reach USD 96.9 Mn by 2032.
The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treatment outcomes and operational efficiency. Supportive regulations, rising R&D investments, and a strong focus on patient-centric care are creating new opportunities for pharmaceutical companies.
The emergence of various surgeries performed by robotics as well as the increase in geriatric population are expected to provide lucrative growth opportunities for players in the safety needles market. Thus, key market players are focused on adopting growth strategies such as partnerships, acquisition, which will drive the India intravenous anesthetic market. For example, in January 29 2023, according to an article published in the journal Statspearl, estimated the increase in prevalence of laparoscopic surgeries which generally involved the use of anesthesia to performed the surgery.
India Intravenous Anesthetic Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2019 as "coronavirus disease 2019" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems with regard to the transportation of drugs from one place to another.
During the pandemic, RA (Regional Anesthesia) had favored as a modality to decrease COVID-19 spread during AGPs (aerosol-generating procedures). For instance, in November 2021, according to an article published in Canada-based journal of Anesthesia the use of regional anesthesia techniques is a better choice for anesthesia provision when possible. Regional anesthesia (RA) has well-known benefits over general anesthesia and is known to improve many patient-related outcomes. The European and American Societies of Regional Anesthesia recommend performing RA as the sole anesthetic technique for managing COVID-19-positive/suspected patients undergoing surgery to improve healthcare safety for both patients and providers.